| O.1 | Approve Financial Statements and Statutory Reports
| For |
| O.2 | Approve Consolidated Financial Statements and Statutory Reports
| For |
| O.3 | Approve Treatment of Losses
| For |
| O.4 | Approve Transaction with SIX Group AG Re: Second Settlement Agreement and Lock-up Agreement
| For |
| O.5 | Approve Transaction with Deutscher Sparkassen Verlag GmbH Re: Amendment to the Business Combination Agreement
| For |
| O.6 | Elect Agnès Audier - Non-Executive Director | For |
| O.7 | Elect Nazan Somer Özelgin - Non-Executive Director | For |
| O.8 | Elect Danielle Lagarde - Non-Executive Director | Oppose |
| O.9 | Elect Lorenz von Habsburg Lothringen - Non-Executive Director | Oppose |
| O.10 | Elect Daniel Schmucki - Non-Executive Director | Oppose |
| O.11 | Renew Appointment of Johannes Dijsselhof as Censor
| Oppose |
| O.12 | Approve Compensation Report of Corporate Officers
| Oppose |
| O.13 | Approve Compensation of Gilles Grapinet, Chairman and CEO
| Oppose |
| O.14 | Approve Compensation of Marc-Henri Desportes, Vice-CEO
| Oppose |
| O.15 | Approve Remuneration Policy of Chairman and CEO
| Oppose |
| O.16 | Approve Remuneration Policy of Vice-CEO
| Oppose |
| O.17 | Approve Remuneration Policy of Chairman of the Board
| For |
| O.18 | Approve Remuneration Policy of Non-Executive Directors
| For |
| O.19 | Authorize Repurchase of Up to 10 Percent of Issued Share Capital
| Oppose |
| E.20 | Authorize Issuance of Equity or Equity-Linked Securities with Preemptive Rights Up to 50 Percent of Issued Capital
| For |
| E.21 | Authorize Issuance of Equity or Equity-Linked Securities without Preemptive Rights Up to 10 Percent of Issued Capital
| Oppose |
| E.22 | Approve Issuance of Equity or Equity-Linked Securities for Up to 10 Percent of Issued Capital Per Year for Private Placements
| Oppose |
| E.23 | Authorize Board to Increase Capital in the Event of Additional Demand Related to Delegation Submitted to Shareholder Vote Under Items 20-22
| Oppose |
| E.24 | Authorize Capital Increase of up to 10 Percent of Issued Capital for Contributions in Kind
| For |
| E.25 | Approve Issuance of Equity or Equity-Linked Securities Reserved for Specific Beneficiaries, up to Aggregate Nominal Amount of EUR 1.5 Million
| Oppose |
| E.26 | Authorize Capital Issuances for Use in Employee Stock Purchase Plans
| Oppose |
| E.27 | Authorize Capital Issuances for Use in Employee Stock Purchase Plans Reserved for Employees and Corporate Officers of International Subsidiaries
| Oppose |
| E.28 | Authorize up to 1.40 Percent of Issued Capital for Use in Stock Option Plans
| Oppose |
| E.29 | Authorize up to 0.50 Percent of Issued Capital for Use in Restricted Stock Plans
| Oppose |
| E.30 | Approve Acquisition of Worldline France SAS, its Valuation and Remuneration
| For |
| E.31 | Authorize Filing of Required Documents/Other Formalities
| For |
